Skip to main content
Log in

Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The present study investigated the prophylactic effects of vitamin D metabolites and vitamin D metabolite combinations on static and dynamic, tetracycline-based, histomorphometric parameters in the axial skeleton of ovariectomized rats. Forty-three Fischer-344 rats (10 weeks old, 130 g each body weight, BW) were either bilaterally ovariectomized (OVX) or sham-operated (SHAM). The rats were allocated into the following groups: SHAM; OVX; OVX+7.5 ng 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3]/rat/day; OVX +15 ng 1α,24R,25-trihydroxyvitamin D3 [1,24,25-(OH)3D3]/rat/day; OVX+75 ng 24R,25-dihydroxyvitamin D3 [24,25(OH)2D3]/rat/day; OVX+7.5 ng 1,25(OH)2D3/rat/ day+15 ng 1,24,25(OH)3D3/rat/day; OVX+7.5 ng 1,25(OH)2D3/rat/day+75 ng 24,25(OH)2D3/rat/day. The vitamin D metabolites were fed orally starting 4 weeks after surgery. Urine and blood samples were collected 12 and 16 weeks postovariectomy, respectively. Sixteen weeks after surgery, all rats were sacrificed, and the first lumbar vertebrae were processed undecalcified for histomorphometric analysis. Ovariectomy induced a highly significant reduction (P<0.001) of cancellous bone mass in the secondary spongiosa of the lumbar vertebral body. The bone loss in OVX rats was accompanied by a distinct elevation of all histomorphometric parameters of bone formation and resorption. 1,25(OH)2D3 and both vitamin D metabolite combinations significantly raised serum calcium levels and prevented the bone loss by inhibiting the increased bone resorption in OVX rats. In the applied dosage, 1,24,25(OH)3D3 and 24,25(OH)2D3 alone were ineffective in preserving the cancellous bone of the lumbar vertebra in OVX rats. We conclude that the oral prophylactic application of low doses of active vitamin D metabolites can effectively prevent the osteopenia induced by ovariectomy in the axial skeleton of the rat.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Reichel H, Koeffler HP, Norman AW (1989) The role of the vitamin D endocrine system in health and disease. N Engl J Med 320: 980–991

    Google Scholar 

  2. Miller SC, Halloran BP, DeLuca HF, Yamada S, Takayama H, Jee WSS (1981) Studies on the role of 24-hydroxylation of vitamin D in the mineralization of cartilage and bone of vitamin D-deficient rats. Calcif Tissue Int 33: 489–497

    Google Scholar 

  3. Brommage R, Jarnagin K, DeLuca HF, Yamada S, Takayama H (1983) 1-But not 24-hydroxylation of vitamin D is required for skeletal mineralization in rats. Am J Physiol 244: E298-E304

    Google Scholar 

  4. Parfitt AM, Mathews CHE, Brommage R, Jarnagin K, DeLuca HF (1984) Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat. J Clin Invest 73: 576–586

    Google Scholar 

  5. Wientroub S, Reddi AH (1982) Vitamin D metabolites and endochondral bone development. In: Silberman M, Slavkin HC (eds) Current advances in skeletogenesis: development, biomineralization, metabolic bone disease. Excerpta Media, Amsterdam, pp 211–217

    Google Scholar 

  6. Atkin I, Pita JC, Ornoy A, Agundez A, Castiglione G, Howell DS (1985) Effects of vitamin D metabolites on healing of low phosphate, vitamin D-deficient induced rickets in rats. Bone 6: 113–123

    Google Scholar 

  7. Tam CS, Heersche JNM, Jones G, Murray TM, Rasmussen H (1986) The effect of vitamin D on bone in vivo. Endocrinology 118: 2217–2224

    Google Scholar 

  8. Lidor C, Atkin I, Ornoy A, Dekel S, Edelstein S (1987) Healing of rachitic lesions in chicks by 24R,25-dihydroxycholecalciferol administered locally into bone. J Bone Miner Res 2: 91–98

    Google Scholar 

  9. Hinek A, Poole AR (1988) The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin). J Bone Miner Res 3: 421–429

    Google Scholar 

  10. Takigawa M, Enomoto M, Shirai E, Nishii Y, Suzuki F (1988) Differential effects of 1α,25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol on the proliferation and the differentiated phenotype of rabbit costal chondrocytes in culture. Endocrinology 122: 831–839

    Google Scholar 

  11. Rambeck WA, Zucker H (1985) Synergistic effects of 1,25(OH)2D3 and 24,25(OH)2D3 on duodenal CaBP in rachitic chicks and on eggshell weight in Japanese quails. Biochem Biophys Res Commun 126: 799–804

    Google Scholar 

  12. Rambeck WA, Weiser H, Meier W, Zucker H (1987) Synergistic effects of 1,25(OH)2D3 and 1,24,25(OH)3D3 in rachitic chicken and rats. In: Kuhlencordt F, Dietsch P, Keck E, Kruse H-P (eds) Generalized bone diseases. Springer, Berlin, New York, pp 169–173

    Google Scholar 

  13. Rambeck WA, Weiser H, Meier W, Zucker H (1988) Synergistic effects of vitamin D metabolites. Ann Nutr Metab 32: 108–111

    Google Scholar 

  14. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K-E, Transbøl I (1980) Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 10: 273–279

    Google Scholar 

  15. Christiansen C, Christensen MS, Rødbro P, Hagen C, Transbøl I (1981) Effect of 1,25-dihydroxyvitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur J Clin Invest 11: 305–309

    Google Scholar 

  16. Riis BJ, Thomsen K, Christiansen C (1986) Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? Calcif Tissue Int 39: 128–132

    Google Scholar 

  17. Aloia JF, Vaswani A, Yeh J, Ellis K, Cohn SH (1987) Treatment of postmenopausal osteoporosis with calcitriol. In: Christiansen C, Johansen JS, Riis BJ (eds) Osteoporosis 1987. Osteopress ApS, Copenhagen, pp 850–852

    Google Scholar 

  18. Caniggia A, Nuti R, Loré F, Martini G, Righi GA, Turchetti V (1988) Long-term calcitriol treatment in postmenopausal osteoporosis: follow-up of two hundred patients. In: Norman AW, Schaefer K, Grigoleit H-G, von Herrath D (eds) Vitamin D. Molecular, cellular and clinical endocrinology. Walter de Gruyter, Berlin, New York, pp 807–816

    Google Scholar 

  19. Gallagher JC, Goldgar D, O'Neill J (1988) Calcitriol therapy in the management of osteoporosis. In: Norman AW, Schaefer K, Grigoleit H-G, von Herrath D (eds) Vitamin D. Molecular, cellular and clinical endocrinology. Walter de Gruyter, Berlin, New York, pp 836–837

    Google Scholar 

  20. Hodgkinson A, Aaron JE, Horsman A, McLachlan MSF, Nordin BEC (1978) Effect of oophorectomy and calcium deprivation on bone mass in the rat. Clin Sci Mol Med 54: 439–446

    Google Scholar 

  21. Wronski TJ, Walsh CC, Ignaszewski LA (1986) Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7: 119–123

    Google Scholar 

  22. Wronski TJ, Dann LM, Horner SL (1989) Time course of vertebral osteopenia in ovariectomized rats. Bone 10: 295–301

    Google Scholar 

  23. Baron R, Tross R, Vignery A (1984) Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anat Rec 208: 137–145

    Google Scholar 

  24. Lindgren JU, Lindholm TS (1979) Effect of 1-alpha-hydroxyvitamin D3 on osteoporosis in rats induced by oophorectomy. Calcif Tissue Int 27: 161–164

    Google Scholar 

  25. Lindgren JU, DeLuca HF (1982) Role of parathyroid hormone and 1,25-dihydroxyvitamin D3 in the development of osteopenia in oophorectomized rats. Calcif Tissue Int 34: 510–514

    Google Scholar 

  26. Izawa Y, Sagara K, Kadota T, Makita T (1985) Comparison of therapeutic usefulness of vitamin D3 analogs on osteoporosis caused by ovariectomy in rats. Acta Vitaminol Enzymol 7: 173–182

    Google Scholar 

  27. Matsumoto T, Ezawa I, Morita K, Kawanobe Y, Ogata E (1985) Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis. J Nutr Sci Vitaminol 31 (suppl): S61-S65

    Google Scholar 

  28. Faugere M-C, Okamoto S, DeLuca HF, Malluche HH (1986) Calcitriol corrects bone loss induced by oophorectomy in rats. Am J Physiol 250: E35-E38

    Google Scholar 

  29. Erben RG, Kohn B, Rambeck WA, Zucker H (1990) Histomorphometric analysis of the rat proximal tibial metaphysis by “linear scanning.” Scanning Microsc 4: 625–640

    Google Scholar 

  30. Kohn B, Erben RG, Rambeck WA, Zucker H (in press) Osteopenia caused by ovariectomy in young female rats and prophylactic effects of 1,25-dihydroxyvitamin D3. J Vet Med

  31. Stegemann H (1958) Mikrobestimmung von Hydroxyprolin mit Chloramin-T und p-Dimethylaminobenzaldehyd (Microassay of hydroxyproline with chloramine T and p-dimethyl aminobenzaldehyde). Z Physiol Chem 311: 41–45

    Google Scholar 

  32. Baron R, Vignery A, Neff L, Silverglate A, Santa Maria A (1983) Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, Florida, pp 13–35

    Google Scholar 

  33. Schenk RK, Olah AJ, Herrmann W (1984) Preparation of calcified tissues for light microscopy. In: Dickson GR (ed) Methods of calcified tissue preparation. Elsevier Science Publishers B.V., Amsterdam, New York, pp 1–56

    Google Scholar 

  34. Kimmel DB, Jee WSS (1980) A quantitative histologic analysis of the growing long bone metaphysis. Calcif Tissue Int 32: 113–122

    Google Scholar 

  35. Parfitt AM (1983) The physiologic and clinical significance of bone histomorphometric data. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, Florida, pp 143–223

    Google Scholar 

  36. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche HH, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 2: 595–610

    Google Scholar 

  37. Kimmel DB, Jee WSS (1983) Measurements of area, perimeter, and distance: details of data collection in bone histomorphometry. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, Florida, pp 89–108

    Google Scholar 

  38. Wronski TJ, Cintrón M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43: 179–183

    Google Scholar 

  39. Turner RT, Wakley GK, Hannon KS, Bell NH (1988) Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 122: 1146–1150

    Google Scholar 

  40. Hui SL, Slemenda CW, Johnson CC, Appledorn CR (1987) Effects of age and menopause on vertebral bone density. Bone Miner 2: 141–146

    Google Scholar 

  41. Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in bone remodeling. J Lab Clin Med 92: 964–970

    Google Scholar 

  42. Pødenphant J, Johansen JS, Thomsen K, Riis BJ, Leth A, Christiansen C (1987) Bone turnover in spinal osteoporosis. J Bone Miner Res 2: 497–503

    Google Scholar 

  43. Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS (1983) Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72: 1396–1409

    Google Scholar 

  44. Parfitt AM (1984) Age-related structural changes in trabecular and cortical bone: cellular mechanisms and biomechanical consequences. Calcif Tissue Int 36: S123-S128

    Google Scholar 

  45. Recker RR, Kimmel DB, Parfitt AM, Davies KM, Keshawarz N, Hinders S (1988) Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Miner Res 3: 133–144

    Google Scholar 

  46. Fallon MD, Whyte MP, Craig RB Jr, Teitelbaum SL (1983) Mast-cell proliferation in postmenopausal osteoporosis. Calcif Tissue Int 35: 29–31

    Google Scholar 

  47. Peck WA, Woods WL (1988) The cells of bone. In: Riggs BL, Melton LJ III (eds) Osteoporosis: etiology, diagnosis, and management. Raven Press, New York, pp 1–44

    Google Scholar 

  48. Frost HM (1976) Some concepts crucial to the effective study of bone turnover and bone balance in human skeletal disease and in experimental models of skeletal physiology and pathophysiology. In: Jaworski ZFG (ed) Proc 1st Workshop on Bone Morphometry. University of Ottawa Press, Ottawa, pp 219–223

    Google Scholar 

  49. Baron R, Vignery A, Horowitz M (1984) Lymphocytes, macrophages and the regulation of bone remodeling. In: Peck WA (ed) Bone and mineral research. Annual 2. Elsevier Science Publishers B.V., Amsterdam, New York, pp 175–243

    Google Scholar 

  50. Gallagher JA, Beneton M, Harvey L, Lawson DEM (1986) Response of rachitic rat bones to 1,25-dihydroxyvitamin D3:biphasic effects on mineralization and lack of effect on bone resorption. Endocrinology 119: 1603–1609

    Google Scholar 

  51. Hock JM, Gunness-Hey M, Poser J, Olson H, Bell NH, Raisz LG (1986) Stimulation of undermineralized matrix formation by 1,25-dihydroxyvitamin D3 in long bones of rats. Calcif Tissue Int 38: 79–86

    Google Scholar 

  52. Wronski TJ, Halloran BP, Bikle DD, Globus RK, Morey-Holton ER (1986) Chronic administration of 1,25-dihydroxyvitamin D3: increased bone but impaired mineralization. Endocrinology 119: 2580–2585

    Google Scholar 

  53. Gunness-Hey M, Gera I, Fonseca J, Raisz LG, Hock JM (1988) 1,25-dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats. Calcif Tissue Int 43: 284–288

    Google Scholar 

  54. Frost HM (1981) Mechanical microdamage, bone remodeling, and osteoporosis: a review. In: DeLuca HF, Frost HM, Jee WSS, Johnston CC, Partitt AM (eds) Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 185–190

    Google Scholar 

  55. Suda T, Miyaura C, Abe E, Kuroki T (1986) Modulation of cell differentiation, immune responses and tumor promotion by vitamin D compounds. In: Peck WA (ed) Bone and mineral research/4. Elsevier Science Publishers B.V., Amsterdam, New York, pp 1–48

    Google Scholar 

  56. Martin TJ, Raisz LG, Rodan G (1987) Calcium regulation and bone metabolism. In: Martin TJ, Raisz LG (eds) Clinical endocrinology of calcium metabolism. Marcel Dekker, New York, Basel, pp 1–52

    Google Scholar 

  57. Boivin G, Mesguich P, Pike JW, Bouillon R, Meunier PJ, Haussler MR, Dubois PM, Morel G (1987) Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. Bone Miner 3: 125–136

    Google Scholar 

  58. Boyce RW, Weisbrode SE (1983) Effect of dietary calcium on the response of bone to 1,25(OH)2D3. Lab Invest 48: 683–689

    Google Scholar 

  59. Okumura H, Yamamuro T, Kasai R, Hayashi T, Tada K, Nishii Y (1988) Effect of 1α-hydroxyvitamin D3 on osteoporosis induced by immobilization combined with ovariectomy in rats. Bone 8: 351–355

    Google Scholar 

  60. Gallagher JC, Jerpbak CM, Jee WSS, Johnson HA, DeLuca HF, Riggs BL (1982) 1,25-dihydroxyvitamin D3: short-and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. Proc Natl Acad Sci USA 79: 3325–3329

    Google Scholar 

  61. Need AG, Horowitz M, Philcox JC, Nordin BEC (1985) 1,25-dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Miner Electrolyte Metab 11: 35–40

    Google Scholar 

  62. Boyce RW, Weisbrode SE (1985) Histogenesis of hyperosteoidosis in 1,25(OH)2D3-treated rats fed high levels of dietary calcium. Bone 6: 105–112

    Google Scholar 

  63. Au WYW (1984) Inhibition by 1,25-dihydroxycholecalciferol of hormonal secretion of rat parathyroid gland in organ culture. Calcif Tissue Int 36: 384–391

    Google Scholar 

  64. Naveh-Many T, Friedlaender MM, Mayer H, Silver J (1989) Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 125: 275–280

    Google Scholar 

  65. Izawa Y, Makita T, Koyama T, Ohnuma N, Ishimoto S, Inoue T, Orimo H (1982) Protecting effect of active vitamin D analogues on the development of osteoporosis in ovariectomized rats. In: Norman AW, Schaefer K, Grigoleit H-G, von Herrath D (eds) Vitamin D. Chemical, biochemical and clinical endocrinology of calcium metabolism. Walter de Gruyter, Berlin, New York, pp 933–935

    Google Scholar 

  66. Gennari C, Francini G, Civitelli R, Bernini M, Nardi P, Maioli E (1982) 1,25-dihydroxycholecalciferol treatment of postmenopausal osteoporosis. In: Menczel J, Robin GC, Makin M, Steinberg R (eds) Osteoporosis. John Wiley & Sons, Chichester New York, pp 364–372

    Google Scholar 

  67. Buchanan JR, Cauffman SW, Greer RB III (1984) Relation of calcium regulating hormones to the pathogenesis of postmenopausal osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL (eds) Osteoporosis. Glostrup Hospital, Copenhagen, pp 275–280

    Google Scholar 

  68. Gallagher JC, Recker RR (1985) A comparison of the effects of calcitriol or calcium supplements on bone in postmenopausal osteoporosis. In: Norman AW, Schaefer K, Grigoleit H-G, von Herrath D (eds) Vitamin D. Chemical, biochemical and clinical update. Water de Gruyter, Berlin, New York, pp 971–975

    Google Scholar 

  69. Mundy GR, Roodman GD (1987) Osteoclast ontogeny and function. In: Peck WA (ed) Bone and mineral research/5. Elsevier Science Publishers B.V., Amsterdam, New York, pp 209–279

    Google Scholar 

  70. Marie PJ, Travers R (1983) Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse. Calcif Tissue Int 35: 418–425

    Google Scholar 

  71. Malluche HH, Matthews C, Faugere M-C, Fanti P, Endres DB, Friedler RM (1986) 1,25-dihydroxyvitamin D maintains bone cell activity, and parathyroid hormone modulates bone cell number in dogs. Endocrinology 119: 1298–1304

    Google Scholar 

  72. Orimo H, Fujita T, Yoshikawa M (1972) Increased sensitivity of bone to parathyroid hormone in ovariectomized rats. Endocrinology 90: 760–763

    Google Scholar 

  73. Heaney RP (1981) Unified concept of the pathogenesis of osteoporosis: updated. In: DeLuca HF, Frost HM, Jee WSS, Johnston CC, Parfitt AM (eds) Osteoporosis: recent advances in pathogenesis and treatment. University Park Press, Baltimore, pp 369–372

    Google Scholar 

  74. Lindgren JU, DeLuca HF (1983) Oral 1,25(OH)2D3: an effective prophylactic treatment for glucocorticoid osteopenia in rats. Calcif Tissue Int 35: 107–110

    Google Scholar 

  75. Goff JP, Reinhardt TA, Beckman MJ, Horst RL (1990) Contrasting effects of exogenous 1,25-dihydroxyvitamin D [1,25-(OH)2D] versus endogenous 1,25-(OH)2D, induced by dietary calcium restriction, on vitamin D receptors. Endocrinology 126: 1031–1035

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erben, R.G., Weiser, H., Sinowatz, F. et al. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int 50, 228–236 (1992). https://doi.org/10.1007/BF00296287

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00296287

Key words

Navigation